Zero Candida

Zero Candida Receives South African Patent for its ZC- 01 device


Zero Candida (the "Company" or "ZC") (TSXV: ZCT), an Israeli FemTech medical device start-up, is pleased to announce the Company has received a final patent from South Africa PCT patent PCT-IL 2023050243 in South Africa. In addition, the company is actively pursuing a global patent portfolio with applications filed worldwide including in the United States, Brazil, and Europe.

Zero-Candida T technologies, Inc. (ZCT) is FemTech developing an AI smart tampon-like device based on a therapeutic light source with a selected wave-length and intensity that can treat the Candida fungus successfully of 99.999% an POC overnight. Vulvo-Vaginal Candidiasis ("VVC") affects about 75% of women globally, and ZCT's device is game changer that has the potential to change the treatment of women and the FemTech industry in the world. The first of its kind of technology using a controlled "Blue Light," destroys the vagina fungus at record speed and without side effects. The treatment is safe and administered using the tampon-like medical device which, according to medical experts, is an optimal solution for removing the fungus altogether and preventing the recurrence of the disease.

Zero Candida is working on creating technology that enables hybrid medicine services to be provided by gynecologists to populations that until now, have had no access to treatment, including among others, those in developing countries. The ZCT device collects and transmits treatment data to the attending physician in real time, for assessment, treatment personalization, and monitoring. Seamless data transfer through a Wi-Fi chip and VoIP, allows for the convenience of remote care and treatment consulting. Another significant advantage of ZCT's device is that the treatment is free from side effects, supporting the growing demand from women to improve their health without the use of chemicals.

Eli Ben Haroosh, Founder & CEO: "Zero Candida is a groundbreaking and game-changing company in the world of women's medicine, accordingly we will hold patents in every possible continent in the world. The company's doctors' team is one of the best in the world in the field of women's health, together with patents around the world, will give the company business strength".

Dr. Asher Holzer, CTO & Director: "As the company's chief scientist, I find it of utmost importance to obtain a patent for the company's inventions and product development. Zero Candida is a world leader in technology that includes hybrid medicine, and technology-based diagnostics".

About Zero Candida:

ZC is a Public FemTech company incorporated under the corporate laws of the State of Israel. ZC is developing an AI smart tampon-like device based on a therapeutic light source with a selected wave-length and intensity that can treat the Candida fungus successfully of 99.999% an POC. Vulvo-Vaginal Candidiasis ("VVC") affects about 75% of women globally, each year 138 million women are affected, and 492 million over their lifetime. Recurrent VVC (4 or more episodes per year) is increasingly documented to become drug resistant to existing treatments and constitutes up to 10% of the cases of VVC. Existing treatments are unable to overcome the high rate of recurrence, since the root cause of the condition is poorly understood and addressed.

ZC has signed pre-clinical agreements with hospitals in Israel and Europe and has successfully completed a safety trial for the use of their pre-clinical device in large animals (sheep). The company is advancing the development of their final product for human use in preparation for a clinical trial that will take place in June 2025.

Zero Candida's device will bring the field of gynecology into the 21st century with hybrid medicine and technology-based diagnostics. At the same time as developing the treatment procedure, Zero Candida is creating technology to enable hybrid medicine services to be offered by gynecologists to populations that until now, received no treatment at all, including, among others, in the developing countries.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release.

Forward-Looking Statements

This news release includes certain statements and information that constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, are forward-looking statements. The Company provides no assurance that forward-looking statements and information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements or information. Accordingly, readers should not place undue reliance on forward-looking statements or information. The Company does not undertake to update any forward-looking statements, other than as required by law. More detailed information about potential factors that could affect financial results is included in the documents filed from time to time with the Canadian securities regulatory authorities by Zero Candida. Readers are cautioned not to place undue reliance on forward-looking statements.

Contact:
Victoria Gamble
E: Victoria@zero-candida.com
P: (647) 874 - 3767

Eli Ben Haroosh, CEO & Founder
E: info@zero-candida.com
Website: www.Zero-Candida.com
LinkedIn: @Zero-Candida

Source

ZCT:CA
The Conversation (0)
Robotic hand and human hand reaching out to touch glowing brain.

ASX AI Stocks: 5 Biggest Companies

Artificial intelligence (AI) continues to evolve and advance rapidly, becoming increasingly integrated in the automation of everyday life and a focal point of growth in the technology sector.

According to a September 2023 report from IDC on worldwide AI spending, Australia, along with Korea and India, is leading the Asia-Pacific region in spending on AI solutions; the three countries are also leading when it comes to AI adoption in the area. Spending in the region, excluding Japan and China, is expected to reach US$28.2 billion by 2027.

Although the AI market is relatively small in Australia, it’s growing. To help investors understand the options available, the Investing News Network used TradingView's stock screener to find the top AI stocks on ASX by market cap. All ASX AI stocks data was current as of April 7, 2025. companies whose businesses are focused mainly on AI were considered.

Keep reading...Show less
Hands holding a glowing AI circuit with digital network icons.

AI Market Update: Q1 2025 in Review

The first quarter of 2025 was dynamic and often volatile for the tech sector. Initial optimism, fueled by investor enthusiasm after a strong 2024, quickly gave way to economic headwinds and market anxieties.

Concerns over monetary policy, global trade tensions and individual company performances led to variations in tech stock valuations, with the Magnificent Seven ultimately experiencing losses by March.

However, Q1 also brought groundbreaking developments in artificial intelligence (AI), intense competition in the semiconductor industry and new developments in AI agents and robotics.

Keep reading...Show less
Man holding magnifying glass.

Tech 5: CoreWeave IPO Falls Short, OpenAI Close to Completing US$40 Billion Funding Round

This week brought a fresh set of challenges to the tech sector, beginning with an announcement from the US Bureau of Industry and Security on Tuesday (March 25) of new export restrictions targeting 80 companies across Asia and the Middle East, impacting some of Big Tech’s key customers.

Consumer confidence weakened, further dampening market sentiment.

This was evidenced by the release of the Conference Board’s Consumer Confidence Index report on Tuesday, and the University of Michigan’s consumer sentiment survey, released on Friday (March 28).

Keep reading...Show less
Hand holding an AI chip.

Global AI Stocks: 9 Biggest Companies in 2025

As the artificial intelligence (AI) market continues to grow, there are many AI stocks for investors to choose from on top exchanges like the NASDAQ, TSX and ASX.

AI technology has made strong inroads into several key industries, including logistics, manufacturing, finance, healthcare, customer service and cybersecurity.

The technology has been around for a long time, but this current wave of buzz comes after the release of OpenAI’s ChatGPT, a generative AI platform. This intelligent chatbot shows how quickly generative AI is advancing, and it has led to many other major tech firms entering the space with their own generative AI offerings or including AI technology into their innovative products.

Keep reading...Show less
RocketBoots

RocketBoots Partners with Global POS Software Vendor to Drive Customer Markets Penetration

Artificial Intelligence software company, RocketBoots Limited (ASX:ROC) (RocketBoots or the Company), is pleased to announce the signing of a partnership agreement with global point-of-sale (POS) vendor, GEBIT Solutions GmbH (Gebit).

Keep reading...Show less

Latest Press Releases

Related News

×